Clinical Trial Update: Prehabilitation Plus ERAS Versus ERAS in Gynecologic Oncology: a Randomized Clinical Trial [Phase 3]

View source ↗

Summary

A Phase 3 randomized trial compares prehabilitation plus ERAS to ERAS alone in gynecologic cancer patients undergoing surgery.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gynecologic Cancer

Snippet

Sponsor: Instituto Brasileiro de Controle do Cancer | Conditions: Gynecologic Cancer, Enhanced Recovery After Surgery | Phase 3 | Status: UNKNOWN